A global network promoting objective and open debate on drug policy
Following the groundbreaking call last month by the World Health Organization (WHO) for countries to stop criminalizing drug use and treat the issue as a public health one, this infographic outlines the stance of a handful of UN agencies toward drug decriminalization.
This note summarizes what was said during the informal luncheon roundtable convened by the United Nations University in July to measure the impacts of drug policy choices on development trajectories and outcome.
While huge numbers of people and organisations all over the world have been calling for drug policy reform, including the Global Commission on Drug Policy, the WHO has now joined our call for the decriminalisation of drug use.
Organized crime and illicit criminal activity undermined essential institutions like the rule of law and delivery of education and health, the United Nations leading expert on drugs and crime told the Economic and Social Council today.
This report provides a summary of what was discussed this year, and attempts to provide some analysis of the key interconnected discussions, debates, emerging issues of concern and recurring themes at the CND.
For Washington and the UN drug control bureaucracy, the extent to which the ongoing drug-control reforms across the Americas are pushing the boundaries of the global legal framework laid down in three UN drug-control conventions has become a delicate issue.
The report aims at helping the international community to address the toll that illicit drug production, trafficking and consumption continues to take on all our societies, by providing a global overview and analysis of developments.
The Global Commission on Drug Policy has launched the campaign, “Hey, We Need to Talk About Drugs”, a series of advertisements addressing key facts and recommendations around the failure of the war on drugs.
Former President of Switzerland, Ruth Dreifuss, and former President of the Portuguese Republic, Jorge Sampaio, call for nations to set up a new international drug strategy for the twenty-first century.